Messinger Michael purchased $2K of ICU
Messinger Michael (Chief Financial Officer) purchased 2,500 shares of SeaStar Medical Holding Corp (ICU) at $0.85 on 2026-11-16.
How this was made
The 30-second read
Why it matters
The disclosure provides a fresh datapoint on insider behavior, but the transaction size is small and lacks accompanying operational or financial catalysts.
Market read
Traders may treat this as a minor sentiment input, not a standalone catalyst.
What to watch
No 10b5-1 plan is indicated, but the filing does not explain motivation; traders should avoid over-weighting insider buys without corroborating fundamentals or guidance.
Background
The article is an SEC Form 4 insider transaction disclosure for SeaStar Medical Holding Corp.
Ticker impact
SeaStar Medical CFO Messinger Michael bought 2,500 shares at $0.8498/share, totaling $2,124.50, per a new SEC Form 4 filing.
Likely limited upside bias as traders note insider buying, but magnitude is too small for a material price catalyst.
This is an SEC Form 4 insider transaction with a low dollar value and no 10b5-1 plan disclosed; it can be sentiment-positive but typically lacks standalone market-moving force.
Market effects
No clear sector read-through from a single, small insider purchase.
None.
None.
Counterpoint
The purchase may be routine compensation-related or opportunistic timing, and the small size reduces signal quality.
Key entities
- issuerSeaStar Medical Holding Corp
Company whose CFO filed an insider purchase on Form 4.
- insiderMessinger Michael
Chief Financial Officer who purchased shares.
